维普中文期刊产品整合服务
6篇 您的检索式:作者名="Edurne A"
    题名 作者 年代 出处 被引量
1A validated solid - liquid extraction method for the HPLC determination of polyphenols in apple tissues Comparison with pressurised liquid extraction显示文摘ROSA M ALEJANDRO B EDURNE C LUIS A BLANCA G FRANCISCA V 2005Talanta2005,,65:1
2Aβ increases neural stem cell activity in senescence-accelerated SAMP8 mice显示文摘María Díaz-Moreno Rafael Hortigüela Ania Gon?alves Irmina García-Carpio Gemma Manich Edurne García-Bermúdez Mireia Moreno-Estellés César Eguiluz Jordi Vilaplana Carme Pelegrí Mar?al Vilar Helena Mira 2013Neurobiology of Aging2013,,:1
3Topoisomerase Ⅱ alpha amplification may predict benefit from adjuvant anthrecyclines in HER2 positive early breast cancer显示文摘Edurne A Socorro M P Maryou B K 2007Breast Cancer Res Treat2007,106,2:1
4Effects of trans-10,cis-12 conjugated linoleic acid on cholesterol metabolism in hypercholesterolaemic hamsters显示文摘Virginia Navarro M. Teresa Macarulla Alfredo Fernández-Quintela Víctor M. Rodríguez Edurne Simón María P. Portillo 2007European Journal of Nutrition2007,,4:1
5Hydrothermal synthesis and crystal structure of the Ni 2 (C 4 H 4 N 2 )(V 4 O 12 )(H 2 O) 2 and Ni 3 (C 4 H 4 N 2 ) 3 (V 8 O 23 ) inorganic–organic hybrid compounds. Thermal, spectroscopic and magnetic studies of the hydrated phase显示文摘Edurne S. Larrea José L. Mesa José L. Pizarro María I. Arriortua Teófilo Rojo 2007Journal of Solid State Chemistry2007,,3:1
6Detection of KRAS G12D in colorectal cancer stool by droplet digital PCR显示文摘AIM To assess KRAS G12 D mutation detection by droplet digital PCR(dd PCR) in stool-derived DNA from colorectal cancer(CRC) patients.METHODS In this study, tumor tissue and stool samples were collected from 70 patients with stage Ⅰ-Ⅳ CRC diagnosed by preoperative biopsy. KRAS mutational status was determined by pyrosequencing analysis of DNA obtained from formalin-fixed paraffinembedded(FFPE) tumor tissues. The KRAS G12 D mutation was then analyzed by dd PCR in FFPE tumors and stool-derived DNA from patients with this point mutation. Wild-type(WT) tumors, as determined by pyrosequencing, were included as controls; analysis of FFPE tissue and stool-derived DNA by dd PCR was performed for these patients as well.RESULTS Among the total 70 patients included, KRAS mutations were detected by pyrosequencing in 32(45.71%), whereas 38(54.29%) had WT tumors. The frequency of KRAS mutations was higher in left-sided tumors(11 located in the right colon, 15 in the left, and 6 in the rectum). The predominant point mutation was KRAS G12 D(14.29%, n = 10), which was more frequent in early-stage tumors(I-IIA, n = 7). In agreement with pyrosequencing results, the KRAS G12 D mutation was detected by dd PCR in FFPE tumor-derived DNA, and only a residual number of mutated copies was found in WT controls. The KRAS G12 D mutation was also detected in stool-derived DNA in 80% of all fecal samples from CRC patients with this point mutation. CONCLUSION dd PCR is a reliable and sensitive method to analyze KRAS G12 D mutation in stool-derived DNA from CRC patients, especially at early stages. This non-invasive approach is potentially applicable to other relevant biomarkers for CRC management.Susana Olmedillas-López Dennis César Lévano-Linares Carmen Laura Aúz Alexandre Luz Vega-Clemente Edurne León Sánchez Alejandro Villagrasa Jaime Ruíz-Tovar Mariano García-Arranz Damián García-Olmo 2017World Journal of Gastroenterology2017,23,39:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费